High frequency of codon 61 K-ras A→T transversions in lung and Harderian gland neoplasms of B6C3F1 mice exposed to chloroprene (2-chloro-1,3-butadiene) for 2 years, and comparisons with the structurally related chemicals isoprene and 1,3-butadiene

Carcinogenesis

Volumn 20, Issue 4, 1999, Pages 657-662

  Sills, R C ^a   Hong, H L ^a   Melnick, R L ^a   Boorman, G A ^a   Devereux, T R ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BUTADIENE; CARCINOGEN; CHLOROPRENE; ISOPRENE; RAS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CODON; CONTROLLED STUDY; FEMALE; GENE MUTATION; HARDER GLAND; LUNG CANCER; MALE; MOUSE; NONHUMAN; ONCOGENE H RAS; ONCOGENE K RAS; PRIORITY JOURNAL;

EID: 0032994402     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.4.657     Document Type: Article

References (49)

1. National Toxicology Program (1996) Toxicology and carcinogenesis studies of chloroprene (CAS no. 126-99-8) in F344/N rats and B6C3F1 mice (inhalation studies). NTP Technical Report 467, NIH Publication no. 96-3957. NIEHS, Research Triangle Park, NC.
2. Melnick, R.L., Sills, R.C., Roycroft, J.H., Chou, B.J., Ragan, H.A. and Miller, R.A. (1994) Isoprene, an endogenous hydrocarbon and industrial chemical, induces multiple organ neoplasia in rodents after 26 weeks of inhalation exposure. Cancer Res., 54, 5333-5339.
3. Melnick, R.L., Roycroft, J.H., Chou, B.J., Ragan, H.A. and Miller, R.A. (1990) Inhalation toxicology of isoprene in F344 rats and B6C3F1 mice following two-week exposures. Environ. Health Perspect., 86, 93-98.
4. Owen, P.E., Glaister, J.R., Graunt, I.F. and Pullinger, D.H. (1987) Inhalation toxicity studies with 1,3-butadiene. Two-year toxicity/carcinogenicity studies in rats. Am. Ind. Hyg. Assoc. J., 48, 407-413.
5. IARC (1987) Chloroprene and Polychloroprene, Some Monomers, Plastics and Synthetic Elastomers and Acrolein. IARC Monographs vol. 19, IARC, Lyon. pp. 131-156.
6. American Conference of Governmental Industrial Hygienists (ACGIH) (1985) Guidelines for the Selection of Chemical Protective Clothing, 2nd edn. ACGIH, Cincinnati, OH, p. 46.
7. Sax, N.I. and Lewis, S.R.J. (1987) Hawley's Condensed Chemical Dictionary, 11th edn. Van Nostrand Reinhold, New York, NY, pp. 271-272.
8. NIOSH (1990) National occupational exposure survey (1981 to 1983), unpublished provisional data as of July 1, 1990. NIOSH, Cincinnati, OH.
9. Khachatrian, E.A. (1972) The occurrence of lung cancer among people working with chloroprene. Vopr. Onkol., 18, 585.
10. Shouqi, L., Quinan, D., Yuqing, L. and Yingfei, L. (1989) Epidemiologic study of cancer mortality among chloroprene workers. Biomed. Environ. Sci., 2, 141-149.
11. Bartsch, H., Malaveille, C., Montesano, R. and Tomatis, L. (1975) Tissue-mediated mutagenicity of vinylidene chloride and 2-chlorobutadiene in Salmonella typhimurium. Nature, 255, 641-643.
12. Bartsch, H., Malaveille, C., Barbin, A. and Planche, G. (1979) Mutagenic and alkylating metabolites of haloethylenes, chlorobutadienes and dichlorobutenes produced by rodent or human liver tissues: evidence for oxirane formation by P450-linked microsomal mono-oxygenases. Arch. Toxicol., 41, 249-277.
13. Westphal, G.A., Blaszkewicz, M., Leutbecher, M., Muller, A., Hallier, E. and Bolt, H.M. (1994) Bacterial mutagenicity of 2-chloro-1,3-butadiene (chloroprene) caused by decomposition products. Arch. Toxicol., 68, 79-84.
14. Sanotskii, I.V. (1976) Aspects of the toxicology ot chloroprene: immediate and long-term effects. Environ. Health Perspect., 17, 85-93.
15. Tice, R.R., Boucher, R., Luke, C.A., Paquette, D.E., Melnick, R.L. and Shelby, M.D. (1988) Chloroprene and isoprene: cytogenetic studies in mice. Mutugenesis, 3, 141-146.
16. Shelby, M.D. (1990) Results of NTP-sponsored mouse cytogenic studies on 1,3-butadiene, isoprene and chloroprene. Environ. Health Perspect., 86, 71-73.
17. Melnick, R.L., Huff, J., Chou, B.J. and Miller, R.A. (1990) Carcinogenicity of 1,3-butadiene in C57BL/6×C3HF1 mice at low exposure concentrations. Cancer Res., 50, 6592-6599.
18. Barbacid, M. (1987) ras genes. Annu. Rev. Biochem., 56, 780-813.
19. Devereux, T.R., Anderson, M.W. and Belinsky, S.A. (1991) Role of ras protooncogene activation in the formation of spontaneous and nitrosamine-induced lung tumors in the resistant C3H mouse. Carcinogenesis, 12, 299-303.
20. 6-methylguanine DNA adduct levels and Ki-ras activation in lung tumors from resistant and susceptible mouse strains. Mol. Carcinogen., 8, 177-185.
21. Barrett, J.C. and Wiseman, R.W. (1987) Cellular and molecular mechanisms of multistep carcinogenesis: relevance to carcinogen risk assessment. Environ. Health Perspect., 76, 65-70.
22. Loechler, E.L. (1996) The role of adduct site-specific mutagenesis in understanding how carcinogen-DNA adducts cause mutations: perspectives, prospects and problems. Carcinogenesis, 17, 895-902.
23. Gill, R.D., Beltran, L., Nettikumara, A.N., Harvery, R.G., Koostra, A. and DiGiovanni, J. (1992) Analysis of point mutations in murine c-Ha-ras of skin tumors initiated with dibenz[a,j]anthracene and derivatives. Mol. Carcinogen., 6, 53-59.
24. Min, Z., Gill, R.D., Cortez, C., Harvey, R.G., Loechler, E.L. and DiGiovanni, J. (1996) Targeted A→T and G→T mutations induced by site-specific deoxyadenosine and deoxyguanosine adducts, respectively, from the (+)-anti-diol epoxide of dibenz|a,j]anthracene in M13mp7L2. Biochemistry, 35, 4128-4138.
25. Goodrow, T.L., Nichols, W.W., Storer, R.D., Anderson, M.W. and Maronpot, R.R. (1994) Activation of H-ras is prevalent in 1,3-butadiene-induced and spontaneously occurring murine Harderian gland tumors. Carcinogenesis, 15, 2665-2667.
26. Hong, H.L., Devereux, T.R., Melnick, R.L., Eldridge, S.R., Greenwell, A., Haseman, J., Boorman, G.A. and Sills, R.C. (1997) Both K-ras and H-ras protooncogene mutations are associated with Harderian gland tumorigenesis in B6C3F1 mice exposed to isoprene for 26 weeks. Carcinogenesis, 18, 783-789.
27. Citti, L., Gervasi, P.G., Turchi, G., Bellucci, G. and Bianchini, R. (1984) The reaction of 3,4-epoxy-1-butene with deoxyguanosine and DNA in vitro: synthesis and characterization of the main adducts. Carcinogenesis, 5, 47-52.
28. 32P-postlabelling. Carcinogenesis, 15, 1903-1910.
29. Holland, J.M. and Fry, R.J. (1982) Neoplasms of the integumentary system and Harderian gland. In Foster, H.L., Small, J.D. and Fox, J.G. (eds) The Mouse in Biomedical Research, vol. IV. Academic Press, New York, NY, pp. 513-528.
30. Huff, J., Cirvello, J., Haseman, J. and Bucher, J. (1991) Chemicals associated with site-specific neoplasia in 1394 long-term carcinogenesis experiments in laboratory rodents. Environ. Health Perspect., 93, 247-270.
31. Marmur, J. (1961) A procedure for isolation of deoxyribonucleic acid from microorganisms. J. Mol. Biol., 3, 208-218.
32. Sills, R.C., Hong, H.L., Greenwell, A., Herbert, R.A., Boorman, G.A. and Devereux, T.R. (1995) Increased frequency of K-ras mutations in lung neoplasms from female B6C3F1 mice exposed to ozone for 24 or 30 months. Carcinogenesis, 16, 1623-1628.
33. Wright, D.K. and Manos, M.M. (1990) Sample preparation from paraffin-embedded tissues. In Innis, M.A., Gelfand, D.H., Sninsky, J.J. and White, T.J. (eds) PCR Protocols: A Guide to Methods and Applications. Academic Press, San Diego, CA, pp. 153-158.
34. Saiki, R.K., Gelfand, D.H., Stoffel, S., Scharf, S.J., Higuchi, R., Horn, G.T., Mullis, K.B. and Erlich, H.A. (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science, 239, 487-490.
35. Devereux, T.R., Foley, J.F. Maronpot, R.R., Kari, F. and Anderson, M.W. (1993) ras proto-oncogene activation in liver and lung tumors from B6C3F1 mice exposed chronically to methylene chloride. Carcinogenesis, 14, 795-801.
36. Sukumuar, S. and Barbacid, M. (1990) Specific patterns of oncogene activation in transplacentally induced tumors. Proc. Natl Acad. Sci. USA, 87, 718-722.
37. Hongyo, T., Buzard, G.S., Calvert, R.J. and Weghorst, C.M. (1993) 'Cold SSCP': a simple, rapid and non-radioactive method for optimized single-strand conformation polymorphism analyses. Nucleic Acids Res., 21, 3637-3642.
38. Tindall, K. and Stankowski, L. (1988) Molecular analysis of spontaneous mutations at the gpt locus in Chinese hamster ovary (A S52) cells. Mutat. Res., 220, 241-253.
39. Goodrow, T. Reynolds, S., Maronpot, R. and Anderson, M. (1990) Activation of K-ras by codon 13 mutations in C57BL/6×C3H F1 mouse tumors induced by exposure to 1,3-butadiene. Cancer Res., 50, 4818-4823.
40. Steen, A., Meyer, K.G. and Recio, L. (1997) Analysis of hprt mutations occurring in human TK6 lymphoblastoid cells following exposure to 1,2,3,4-diepoxybutane. Mutagenesis, 12, 61-67.
41. Cochrane, J.E. and Skopek, T.R. (1994) Mutagenicity of butadiene and its epoxide metabolites: II. Mutational spectra of butadiene 1,2-epoxybutene and diepoxybutane at the hprt locus in splenic T cells from exposed B6C3F1 mice. Carcinogenesis, 15, 719-723.
42. Sisk, S.S., Pluta, L.J., Bond, J.A. and Recio, L. (1994) Molecular analysis of lacI mutants from bone marrow of B6C3F1 transgenic mice following inhalation exposure to 1,3-butadiene. Carcinogenesis, 15, 471-477.
43. Reardon, D.B., Bigger, C.A.H. and Dipple, A. (1990) DNA polymerase action on bulky deoxyguanosine and deoxyadenosine adducts. Carcinogenesis, 11, 165-168.
44. Chakravarti, D., Pelling, J.C., Cavalieri, E.L. and Rogan, E.G. (1995) Relating aromatic hydrocarbon-induced DNA adducts and c-Ha-ras mutations in mouse skin papillomas: the role of apurinic sites. Proc. Natl Acad. Sci. USA, 92, 10422-10426.
45. Cochrane, J.E. and Skopek, T.R. (1994) Mutagenicity of butadiene and its epoxide metabolites. I. Mutagenic potential of 1,2-epoxybutene, 1,2,3,4-diepoxybutane and 3,4-epoxy-1,2-butanediol in cultured human lymphoblasts. Carcinogenesis, 15, 713-717.
46. Gervasi, P.G., Citti, L., Del Monte, M. Longo, V. and Benetti, D. (1985) Mutagenicity and chemical reactivity of epoxidic intermediates of the isoprene metabolism and other structurally related compounds. Mutat. Res., 156, 77-82.
47. Swenberg, J.A., La, D.K., Scheller, N.A. and Wu, K. (1995) Dose-response relationships for carcinogens. Toxicol. Lett., 82/83, 751-756.
48. Goodman, J.I. (1998) The traditional toxicologic paradigm is correct: dose influences mechanism. Environ. Health Perspect., 106, 285-288.
49. Wei, S.-J.C., Chang, R.L., Wong, C. et al. (1991) Dose-dependent differences in the profile of mutations induced by an ultimate carcinogen from benzo[a]pyrene. Proc. Natl Acad. Sci. USA, 88, 11227-11230.